How people undergoing genomic sequencing interpret and react to varied secondary findings with limited actionability
Participants' short-term well-being was not reduced by receiving LMA-SFs. Their interpretations suggested varied personal utilities and the need for post-test resources to aid understanding of these types of results and their health significance.
Authors
- Jonathan S. Berg (ORCID: https://orcid.org/0000-0003-2360-2664)
- Haoyang Yan (ORCID: https://orcid.org/0000-0001-9195-355X)
- Kristy Lee (ORCID: https://orcid.org/0000-0002-8338-7989)
- Margaret Waltz (ORCID: https://orcid.org/0000-0002-2582-145X)
- Julianne O’Daniel (ORCID: https://orcid.org/0000-0001-5843-4432)
- Myra I. Roche (ORCID: https://orcid.org/0000-0001-9680-6006)
- Gail E. Henderson (ORCID: https://orcid.org/0000-0002-4968-7064)
- Ann Katherine M. Foreman (ORCID: https://orcid.org/0000-0002-0293-6609)
- Christine Rini (ORCID: https://orcid.org/0000-0002-3169-3626)
Institutions
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Alabama at Birmingham (US)
Publication Details
- Journal
- Personalized Medicine
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1080/17410541.2025.2476392
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health